NAFLD/MAFLD: New Evidence

被引：1
|
作者：
Mantovani, Alessandro [1 ]
Dalbeni, Andrea [2 ,3 ]
机构：
[1] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Sect Endocrinol Diabet & Metab, I-37126 Verona, Italy
[2] Univ & Azienda Osped Univ Integrata Verona, Sect Gen Med C, I-37126 Verona, Italy
[3] Univ & Azienda Osped Univ Integrata Verona, Liver Unit, I-37126 Verona, Italy
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 08期
关键词：
D O I：
10.3390/ijms24087241
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The NAFLD-MAFLD debate through the lens of the Arab world
    Tharwat, Mina
    Medhat, Mohammed A.
    El-Kassas, Mohamed
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2022, 28 (06): : 413 - 416
  • [42] MAFLD and NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality?
    Lombardi, Rosa
    Cespiati, Annalisa
    Francione, Paolo
    Cinque, Felice
    Fargion, Silvia
    Fracanzani, Anna Ludovica
    METABOLISM AND TARGET ORGAN DAMAGE, 2021, 1 (02):
  • [43] Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study
    Yoo, Tae Kyung
    Lee, Mi Yeon
    Kim, Seong Hwan
    Zheng, Ming-Hua
    Targher, Giovanni
    Byrne, Christopher D.
    Sung, Ki-Chul
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (05) : 947 - 955
  • [44] MAFLD EXCEEDS NAFLD IN IDENTIFICATION OF PATIENTS WITH SIGNIFICANT HEPATIC FIBROSIS
    Kawaguchi, Takumi
    Eslam, Mohammed
    Yamamura, Sakura
    Tsutsumi, Tsubasa
    Nakano, Dan
    Yoshinaga, Shinobu
    Takahashi, Hirokazu
    Anzai, Keizo
    George, Jacob
    Torimura, Takuji
    HEPATOLOGY, 2020, 72 : 982 - 982
  • [45] Letter to the editor: Pitfalls in the outcome differences between NAFLD and MAFLD
    Attia, Dina
    Gomaa, Ahmed
    Abdel Alem, Shereen
    HEPATOLOGY, 2022, 76 (05) : E100 - E100
  • [46] Prognosis of MAFLD vs. NAFLD and implications for a nomenclature change
    Wong, Vincent Wai-Sun
    Lazarus, Jeffrey, V
    JOURNAL OF HEPATOLOGY, 2021, 75 (06) : 1267 - 1270
  • [47] Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-2018
    Pan, Jie
    Wu, Feilong
    Chen, Mingtao
    He, Jinsen
    Gu, Yingying
    Pei, Lei
    Lai, Xuye
    Zhang, Zhenfeng
    Yang, Lili
    DIABETES & METABOLISM, 2024, 50 (06)
  • [48] Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
    Nguyen, Vy H.
    Le, Michael H.
    Cheung, Ramsey C.
    Nguyen, Mindie H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (10) : 2172 - +
  • [49] Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD
    Imai, Jin
    Takashimizu, Shinji
    Suzuki, Nana
    Ohshinden, Kana
    Sawamoto, Kana
    Mishima, Yusuke
    Tsuruya, Kota
    Arase, Yoshitaka
    Yamano, Mitsuhiko
    Kishimoto, Noriaki
    Yamada, Chizumi
    Inoue, Nagamu
    Moriyama, Kengo
    Baba, Akiyasu
    Suzuki, Hidekazu
    Kagawa, Tatehiro
    Nishizaki, Yasuhiro
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Response to: Comparison of MAFLD and NAFLD diagnostic criteria in real world
    Nguyen, Vy H.
    Le, Michael H.
    Henry, Linda
    Cheung, Ramsey
    LIVER INTERNATIONAL, 2020, 40 (12) : 3145 - 3145
12345